122 related articles for article (PubMed ID: 34387602)
1. CEBPB knockdown sensitizes nasopharyngeal carcinoma cells to cisplatin by promoting the expression of serine protease inhibitor Kazal-type 5.
Liu H; Huang Q; Lv Y; Dong Y; Song D
Anticancer Drugs; 2022 Jan; 33(1):e327-e335. PubMed ID: 34387602
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the Tumor Suppressor Gene SPINK5 via EHMT2 Induces the Oral Squamous Cell Carcinoma Development.
Sun S; Su G; Zheng X
Mol Biotechnol; 2024 Feb; 66(2):208-221. PubMed ID: 37071303
[TBL] [Abstract][Full Text] [Related]
3. PGC1α/CEBPB/CPT1A axis promotes radiation resistance of nasopharyngeal carcinoma through activating fatty acid oxidation.
Du Q; Tan Z; Shi F; Tang M; Xie L; Zhao L; Li Y; Hu J; Zhou M; Bode A; Luo X; Cao Y
Cancer Sci; 2019 Jun; 110(6):2050-2062. PubMed ID: 30945396
[TBL] [Abstract][Full Text] [Related]
4. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
[No Abstract] [Full Text] [Related]
5. miR-1278 sensitizes nasopharyngeal carcinoma cells to cisplatin and suppresses autophagy via targeting ATG2B.
Zhao Y; Wang P; Wu Q
Mol Cell Probes; 2020 Oct; 53():101597. PubMed ID: 32407879
[TBL] [Abstract][Full Text] [Related]
6. SATB1 Knockdown Inhibits Proliferation and Invasion and Decreases Chemoradiation Resistance in Nasopharyngeal Carcinoma Cells by Reversing EMT and Suppressing MMP-9.
Zhou D; Ye C; Pan Z; Deng Y
Int J Med Sci; 2021; 18(1):42-52. PubMed ID: 33390772
[No Abstract] [Full Text] [Related]
7. Quercetin acts as a novel anti-cancer drug to suppress cancer aggressiveness and cisplatin-resistance in nasopharyngeal carcinoma (NPC) through regulating the yes-associated protein/Hippo signaling pathway.
Li T; Li Y
Immunobiology; 2023 Mar; 228(2):152324. PubMed ID: 36608594
[TBL] [Abstract][Full Text] [Related]
8. MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma.
Bissey PA; Teng M; Law JH; Shi W; Bruce JP; Petit V; Tsao SW; Yip KW; Liu FF
BMC Cancer; 2020 Jun; 20(1):597. PubMed ID: 32586280
[TBL] [Abstract][Full Text] [Related]
9. SPINK5 inhibits esophageal squamous cell carcinoma metastasis via immune activity.
Chen J; Lu J; Chen Z; Liu Z; Sun Y; He S; Mi Y; Gao Y; Shen D; Lin Q
J Gene Med; 2024 Mar; 26(3):e3667. PubMed ID: 38442944
[TBL] [Abstract][Full Text] [Related]
10. ARNTL hypermethylation promotes tumorigenesis and inhibits cisplatin sensitivity by activating CDK5 transcription in nasopharyngeal carcinoma.
Peng H; Zhang J; Zhang PP; Chen L; Tang LL; Yang XJ; He QM; Wen X; Sun Y; Liu N; Li YQ; Ma J
J Exp Clin Cancer Res; 2019 Jan; 38(1):11. PubMed ID: 30621723
[TBL] [Abstract][Full Text] [Related]
11. CircIPO7 Promotes Nasopharyngeal Carcinoma Metastasis and Cisplatin Chemoresistance by Facilitating YBX1 Nuclear Localization.
Hong X; Li Q; Li J; Chen K; He Q; Zhao Y; Liang Y; Zhao Y; Qiao H; Liu N; Ma J; Li Y
Clin Cancer Res; 2022 Oct; 28(20):4521-4535. PubMed ID: 35917517
[TBL] [Abstract][Full Text] [Related]
12. Circular RNA TGFBR2 acts as a ceRNA to suppress nasopharyngeal carcinoma progression by sponging miR-107.
Li W; Lu H; Wang H; Ning X; Liu Q; Zhang H; Liu Z; Wang J; Zhao W; Gu Y; Li H; Sun X; Hu L; Wang D
Cancer Lett; 2021 Feb; 499():301-313. PubMed ID: 33160003
[TBL] [Abstract][Full Text] [Related]
13. Regulatory Mechanism of lncRNA CTBP1-AS2 in Nasopharyngeal Carcinoma Cell Proliferation and Apoptosis via the miR-140-5p/BMP2 Axis.
Huang B; Li Y; Deng Z; Lan G; Si Y; Zhou Q
Protein Pept Lett; 2022; 29(7):621-630. PubMed ID: 35894463
[TBL] [Abstract][Full Text] [Related]
14. Transducin β-like 1 X-linked receptor 1 suppresses cisplatin sensitivity in nasopharyngeal carcinoma via activation of NF-κB pathway.
Chen SP; Yang Q; Wang CJ; Zhang LJ; Fang Y; Lei FY; Wu S; Song LB; Guo X; Guo L
Mol Cancer; 2014 Aug; 13():195. PubMed ID: 25145705
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin suppresses proliferation, migration and invasion of nasopharyngeal carcinoma cells in vitro by repressing the Wnt/β-catenin/Endothelin-1 axis via activating B cell translocation gene 1.
Yin P; Song G; Jiang Z
Cancer Chemother Pharmacol; 2018 May; 81(5):863-872. PubMed ID: 29536130
[TBL] [Abstract][Full Text] [Related]
16. BEX3 contributes to cisplatin chemoresistance in nasopharyngeal carcinoma.
Gao W; Li JZ; Chen SQ; Chu CY; Chan JY; Wong TS
Cancer Med; 2017 Feb; 6(2):439-451. PubMed ID: 28083995
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of lncRNA ANRIL represses tumorigenicity and enhances cisplatin-induced cytotoxicity via regulating microRNA let-7a in nasopharyngeal carcinoma.
Wang Y; Cheng N; Luo J
J Biochem Mol Toxicol; 2017 Jul; 31(7):. PubMed ID: 28117929
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA PXN-AS1-L promotes the malignancy of nasopharyngeal carcinoma cells via upregulation of SAPCD2.
Jia X; Niu P; Xie C; Liu H
Cancer Med; 2019 Aug; 8(9):4278-4291. PubMed ID: 31173488
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-142 promotes the development of nasopharyngeal carcinoma through targeting PTEN.
Li DP; Chai W; Liu YH; Xu TT; Huang H
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3806-3812. PubMed ID: 31115007
[TBL] [Abstract][Full Text] [Related]
20. LncRNA THOR attenuates cisplatin sensitivity of nasopharyngeal carcinoma cells via enhancing cells stemness.
Gao L; Cheng XL; Cao H
Biochimie; 2018 Sep; 152():63-72. PubMed ID: 29959065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
